Have a personal or library account? Click to login
Evaluation of acute/late toxicity and local recurrence in Τ1-Τ2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT) Cover

Evaluation of acute/late toxicity and local recurrence in Τ1-Τ2 glottic carcinoma treated with accelerated hypofractionated 3D-conformal external beam radiotherapy (3D-CRT)

Open Access
|May 2013

References

  1. 1. Zygogianni A, Kyrgias G, Mystakidou K, Antypas C, Kouvaris J, Papadimitriou C, et al. Potential role of the alcohol and smoking in the squamous cell carcinoma of the head and neck: review of the current literature and new perspectives. Asian Pac J Cancer Prev 2011; 12: 339-44.
  2. 2. Krengli M, Policarpo M, Gambaro G, Panella M, Manfredda I, Alyffa P, et al. Voice quality after treatment for T1a glottic carcinoma - radiotherapy versus laser coredctomy. Acta Oncol 2004; 43: 284-9.10.1080/02841860410026233
  3. 3. Goor KM, Peeters AJ, Mahieu HF, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM, et al. Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life and voice quality. Head Neck 2007; 29: 128-36.10.1002/hed.20500
  4. 4. Loughran S, Calder N, MacGregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottis cancer. Clin Otolaryngol 2005; 30: 42-7.10.1111/j.1365-2273.2004.00919.x
  5. 5. Rhys-Evans P, Montgomery PQ, Gullane PJ. Principles and practice of head and neck oncology. London: Martin Dunitz; 2003.10.1201/9781482297119
  6. 6. Kazi R, Venkitaran R, Johnson C, Prasad V, Clarke P, Newbold K, et al. Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiother Oncol 2008; 87: 230-6.10.1016/j.radonc.2008.01.006
  7. 7. Plataniotis G, Kouvaris J, Hatzimichalis H, Papavasiliou CG, Vlachos L. Results of radiotherapy for T1 carcinoma of the glottis by fractions of 2.3 Gy per day. Acta Oncol 1997; 36; 342-3.10.3109/02841869709001275
  8. 8. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int JRadiat Oncol Biol Phys 2010; 76(3 Suppl): S10-9.10.1016/j.ijrobp.2009.07.1754
  9. 9. Fowler J. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-94.10.1259/0007-1285-62-740-679
  10. 10. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol BiolPhys 1991; 21: 109-22.10.1016/0360-3016(91)90171-Y
  11. 11. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time-dose factors in radiotherapy: a review of the human data. RadiotherOncol 1990; 19: 219-35.10.1016/0167-8140(90)90149-Q
  12. 12. Pesznyák C, Polgár I, Weisz C, Király R, Zaránd P. Verification of quality parameters for portal images in radiotherapy. Radiol Oncol 2011; 45: 68-74.10.2478/v10019-010-0052-6
  13. 13. Zygogianni A, Kyrgias G, Kouvaris J, Antypas C, Theodorou K, Papageorgiou S, et al. Re-irradiation in head and neck cases using IMRT technique: a retrospective study with toxicity and survival report. Head Neck Oncol 2012; 4: 78.
  14. 14. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital experience. Radiother Oncol 2003; 68: 105-11.10.1016/S0167-8140(03)00059-8
  15. 15. Short S, Krawitz H, Macann A, West T, Morton RP, McIvor NP, et al. T1N0/ T2N0 glottic carcinoma: a comparison of two fractionation schedules. AustrRad 2006; 50: 152-7.10.1111/j.1440-1673.2006.01559.x
  16. 16. Dinshaw KA, Sharma V, Agarwal JP, Ghosh S, Havaldar R. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/ complications. Int J Radiat Oncol Biol Phys 2000; 48: 723-35.10.1016/S0360-3016(00)00635-0
  17. 17. Parsons JT, Greene BD, Speer TW, Kirkpatrick SA, Barhorst DB, Yanckowitz T. Treatment of early and moderately advanced vocal cord carcinoma with 6MV x-rays. Int J Radiat Oncol Biol Phys 2001; 50: 953-9.10.1016/S0360-3016(01)01472-9
  18. 18. Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Clinical radiobiology of glottis T1 squamous cell carcinoma. Int J Radiat Oncol BiolPhys 1999; 43: 101-6.10.1016/S0360-3016(98)00375-7
  19. 19. Onimaru R, Hasegawa M, Yasuda K, Homma A, Oridate N, Fukuda S, et al. Radiotherapy for glottic T1N0 carcinoma with slight hypofractionation and standard overall treatment time: Importance of overall treatment time. JpnJ Clin Oncol 2011; 41: 103-19.10.1093/jjco/hyq153
  20. 20. Duncan W, MacDougall RH, Kerr GR, Downing D. Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. RadiotherOncol 1996; 41: 203-7.10.1016/S0167-8140(96)01838-5
  21. 21. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose and overall time on local control of T1-T2 glottic cancinoma. Int J Radiat Oncol Biol Phys 1997; 39: 115-26.10.1016/S0360-3016(97)00284-8
  22. 22. Yu E, Shenouda G, Beaudet MP. Impact of radiation therapy fraction size on local control of early glottis carcinoma. Int J Radiat Oncol Biol Phys 1997; 37: 587-91.10.1016/S0360-3016(96)00578-0
  23. 23. Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital expperience. Radiother Oncol 2003; 68: 105-11.10.1016/S0167-8140(03)00059-8
  24. 24. Agarwal J, Baccher GK, Waghmare CM, Mallick I, Ghosh-Laskar S, Budrukkar A, et al. Factors affecting the quality of voice in the early glottis cancer treated with radiotherapy. Radiother Oncol 2009; 90: 177-82.10.1016/j.radonc.2008.09.01618937990
  25. 25. Di Nicola L, Gravina GL, Marampon F, Bonfili P, Buonopane S, Di Staso M, et al. The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer. OncolReports 2010; 24: 1383-8.
  26. 26. Cheah NL, Lupton S, Marshall A, Hartley A, Glaholm J. Outcome of the T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham Experience. Clin Oncol 2009; 21: 494-501.10.1016/j.clon.2009.02.00819375900
DOI: https://doi.org/10.2478/raon-2013-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 185 - 191
Published on: May 21, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Vassilis E. Kouloulias, Anna Zygogianni, Eftychia Mosa, Kalliopi Platoni, John Georgakopoulos, Christos Antypas, Ivelina Beli, Maria Tolia, Paulos Maragoudakis, Ioannis Giotakis, Zisis Papas, Amanda Psyrri, Nikolaos Kelekis, John Kouvaris, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.